Language
English
Publication Date
9-15-2023
Journal
STAR Protocols
DOI
10.1016/j.xpro.2023.102386
PMID
37379217
PMCID
PMC10331592
PubMedCentral® Posted Date
6-27-2023
PubMedCentral® Full Text Version
Post-print
Abstract
Dysbiosis of the gut microbiome is implicated in the growing burden of non-communicable chronic diseases, including neurodevelopmental disorders, and both preclinical and clinical studies highlight the potential for precision probiotic therapies in their prevention and treatment. Here, we present an optimized protocol for the preparation and administration of Limosilactobacillus reuteri MM4-1A (ATCC-PTA-6475) to adolescent mice. We also describe steps for performing downstream analysis of metataxonomic sequencing data with careful assessment of sex-specific effects on microbiome composition and structure.
For complete details on the use and execution of this protocol, please refer to Di Gesù et al.1
Keywords
Male, Female, Animals, Mice, Gastrointestinal Microbiome, Microbiota, Limosilactobacillus reuteri, Probiotics
Published Open-Access
yes
Recommended Citation
Di Gesù, Claudia M; Matz, Lisa M; Fultz, Robert; et al., "Monospecies Probiotic Preparation and Administration With Downstream Analysis of Sex-Specific Effects on Gut Microbiome Composition in Mice" (2023). Faculty, Staff and Students Publications. 8941.
https://digitalcommons.library.tmc.edu/baylor_docs/8941
Graphical Abstract